KobayashiTSawanoSItohTKosakaKHirayamaHKasuyaY. The pharmacokinetics of insulin after continuous subcutaneous infusion or bolus subcutaneous injection in diabetic patients. Diabetes.1983;32 (4): 331–6.
2.
WaldhäuslWKBratusch-MarrainPRVierhapperHNowotnyP. Insulin pharmacokinetics following continuous infusion and bolus injection of regular porcine and human insulin in healthy man. Metabolism.1983;32 (5): 478–86.
3.
SteinerSHompeschMPohlRSimmsPFlackeFMohrTPfütznerAHeinemannL. A novel insulin formulation with a more rapid onset of action. Diabetologia.2008;51 (9): 1602–6.
4.
HeinemannLHompeschMFlackeFSimmsPPohlRAlbusKPfütznerASteinerS. Reduction of postprandial glycemic excursions in patients with type 1 diabetes: A novel human insulin formulation versus a rapid-acting insulin analog and regular human insulin. J Diabetes Sci Technol.2011;5 (3): 681–6.
5.
HeinemannL. Insulin pump therapy: What is the evidence for using different types of boluses for coverage of prandial insulin requirements?. J Diabetes Sci Technol.2009;3 (6): 1490–500.
6.
LuijfYMvan BonACHoekstraJBDeVriesJH. Premeal injection of rapid-acting insulin reduces postprandial glycemic excursions in type 1 diabetes. Diabetes Care.2010;33 (10): 2152–5.
7.
HeinemannL. Insulin absorption from lipodystrophic areas: A (neglected) source of trouble for insulin therapy?. J Diabetes Sci Technol.2010;4 (3): 750–3.
8.
PettisRJGinsbergBHirschLSutterDKeithSMcVeyEHarveyNGHompeschMNosekLKapitzaCHeinemannL. Intradermal microneedle delivery of insulin lispro achieves faster insulin absorption and insulin action than subcutaneous injection. Diabetes Technol Ther.2011;13 (4): 435–42.
9.
PettisRJHirschLKapitzaCNosekLHövelmannUKurthHJSutterDEHarveyNGHeinemannL. Microneedle-based intradermal versus subcutaneous administration of regular human insulin or insulin lispro: Pharmacokinetics and postprandial glycemic excursions in patients with type 1 diabetes. Diabetes Technol Ther.2011;13 (4): 443–50.
10.
HarveyAJKaestnerSASutterDEHarveyNGMiksztaJAPettisRJ. Microneedle-based intradermal delivery enables rapid lymphatic uptake and distribution of protein drugs. Pharm Res.2011;28 (1): 107–16.
11.
SwanKLDziuraJDSteilGMVoskanyanGRSikesKASteffenATMartinMLTamborlaneWVWeinzimerSA. Effect of age of infusion site and type of rapid-acting analog on pharmacodynamic parameters of insulin boluses in youth with type 1 diabetes receiving insulin pump therapy. Diabetes Care.2009;32 (2): 240–4.